[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619820":3},{"organization":4,"outcomesModule":7,"designInfo":16,"detailedDescription":15,"studyPopulation":15,"armGroups":22,"interventions":38,"overallOfficials":15,"centralContacts":15,"locations":46,"responsibleParty":57,"collaborators":15,"id":59,"slug":15,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":15,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":67,"maxAge":15,"enrollmentInfo":68,"targetDuration":15,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":15,"overallStatus":77,"whyStopped":15,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Daewon Pharmaceutical Co., Ltd.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":15,"otherOutcomes":15},[9,13],{"measure":10,"description":11,"timeFrame":12},"AUC0-t","Pharmacodynamic DW5524","up to 8 hour",{"measure":14,"description":11,"timeFrame":12},"Cmax",null,{"allocation":17,"interventionModel":18,"interventionModelDescription":15,"primaryPurpose":19,"observationalModel":15,"timePerspective":15,"maskingInfo":20},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":21,"maskingDescription":15,"whoMasked":15},"NONE",[23,28,31,34],{"label":24,"type":25,"description":24,"interventionNames":26},"Group1","EXPERIMENTAL",[27],"Drug: DW5524",{"label":29,"type":25,"description":29,"interventionNames":30},"Group2",[27],{"label":32,"type":25,"description":32,"interventionNames":33},"Group3",[27],{"label":35,"type":25,"description":35,"interventionNames":36},"Group4",[37],"Drug: DW5524-A",[39,43],{"type":40,"name":41,"description":41,"armGroupLabels":42,"otherNames":15},"DRUG","DW5524",[24,29,32],{"type":40,"name":44,"description":44,"armGroupLabels":45,"otherNames":15},"DW5524-A",[35],[47],{"facility":48,"status":15,"city":49,"state":15,"zip":15,"country":50,"countryCode":15,"cosmosGeoPoint":51,"geoPoint":56,"contacts":15},"Chungbuk National University Hospital","Cheongju-si","South Korea",{"type":52,"coordinates":53},"Point",[54,55],127.48972,36.63722,{"lat":55,"lon":54},{"type":58,"investigatorFullName":15,"investigatorTitle":15,"investigatorAffiliation":15,"oldNameTitle":15,"oldOrganization":15},"SPONSOR","100619820",false,"NCT07349589","Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers","A Randomized, Open-label, Single-dose, Parallel-design, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers","Inclusion Criteria:\n\n* Healthy adult volunteers aged 19 years or older at the time of screening\n* Individuals weighing 50.0 kg or more and having a body mass index (BMI) between 18.0 kg\u002Fm2 and 30.0 kg\u002Fm2 at the time of screening\n\nExclusion Criteria:\n\n* Those with a current or past medical history of clinically significant liver, kidney, nervous, mental, respiratory, endocrine, blood disease, tumor, genitourinary, cardiovascular, digestive, or musculoskeletal diseases.",true,"ALL","19 Years",{"count":69,"type":70},48,"ESTIMATED","INTERVENTIONAL",[73],"PHASE1","This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5524 in healthy adult volunteers.",[76],"Healthy Adult","NOT_YET_RECRUITING","2026-01-14",{"date":80,"type":81},"2026-01-20","ACTUAL",{"date":83,"type":70},"2026-02-01",{"date":85,"type":70},"2026-12-01",{"name":5,"class":6},1]